Related Experiment Videos
Antifungal agents: chemotherapeutic targets and immunologic strategies
N H Georgopapadakou1, T J Walsh
1Department of Oncology, Roche Research Center, Nutley, New Jersey 07110, USA.
Antimicrobial Agents and Chemotherapy
|February 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Meropenem/vaborbactam fixed combination for the treatment of patients with complicated urinary tract infections.
Drugs of today (Barcelona, Spain : 1998)·2017
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy.
Clinical pharmacology and therapeutics·2016
Entomophthoramycosis: a neglected tropical mycosis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2016
Fusobacterium necrophorum otitis and mastoiditis in infants and young toddlers.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016
The impact of disease activity and tumour necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis.
Clinical and experimental immunology·2016
L2 β-lactamase contributes to ceftolozane-tazobactam resistance in Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy·2026
Phage-first treatment results in subpopulation-driven collateral sensitivity to beta-lactams in an extensively drug-resistant Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy·2026
Population pharmacokinetics of piperacillin/tazobactam in critically ill pediatric patients.
Antimicrobial agents and chemotherapy·2026
XAB06, a glyco-humanized broad-spectrum anti-Pseudomonas aeruginosa polyclonal antibody, protects mice in a lethal sepsis model.
Antimicrobial agents and chemotherapy·2026
In vitro activity profiles and temporal trends in reduced susceptibility to azoles in Coccidioides in the United States.
Antimicrobial agents and chemotherapy·2026
Advancements in pharmaceutical research on traditional Chinese medicine-metal complexes.
Journal of pharmaceutical analysis·2026
NMDA subunit 2B-selective negative allosteric modulator satoprodil (BI 1569912) as mono- and adjunctive therapy in patients with major depressive disorder: results from two phase 2 randomized, controlled trials.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Therapeutic effect of curdlan in experimental visceral leishmaniasis is mediated by activation of NLRP3 inflammasome.
Experimental parasitology·2026
Chemical profiling of Egregia menziesii and anti-inflammatory potential in LPS-activated RAW 264.7 macrophages.
Molecular biology reports·2026